Select filter conditions
Specialty
Select filter conditions
Solutions
Select filter conditions
Procedure
Category
Found 6 Results
PTCA Balloons
Accuforce™
Accuforce™ non-compliant PTCA balloon catheter offers great balance between high pressure and high resistance, accurate dilatation and advanced deliverability.
Accuforce™ non-compliant PTCA balloon catheter offers great balance between high pressure and high resistance, accurate dilatation and advanced deliverability.
PTCA Guidewires
Runthrough™ NS family
Runthrough™ NS PTCA Guidewire supports a wide range of PTCA scenarios, from serving as a workhorse to tackling challenging cases.
Runthrough™ NS PTCA Guidewire supports a wide range of PTCA scenarios, from serving as a workhorse to tackling challenging cases.
PTCA Balloons
Ryurei™
Ryurei™ semi-compliant PTCA balloon catheter has superior crossability thanks to the combination of low distal profiles and Terumo's hydrophilic Mcoat™.
Ryurei™ semi-compliant PTCA balloon catheter has superior crossability thanks to the combination of low distal profiles and Terumo's hydrophilic Mcoat™.
Stents
Ultimaster™
Ultimaster™ Sirolimus Eluting Coronary Stent System is the most studied reliable Biodegradable Polymer-DES, with over 50,000 patients worldwide.
Ultimaster™ Sirolimus Eluting Coronary Stent System is the most studied reliable Biodegradable Polymer-DES, with over 50,000 patients worldwide.
Stents
Ultimaster™ Nagomi™
Ultimaster™ Nagomi™ Sirolimus Eluting Coronary Stent System is the most studied reliable Biodegradable Polymer-DES, with over 50,000 patients worldwide.
Ultimaster™ Nagomi™ Sirolimus Eluting Coronary Stent System is the most studied reliable Biodegradable Polymer-DES, with over 50,000 patients worldwide.
Stents
Ultimaster™ Tansei™
Ultimaster™ Tansei™ Sirolimus Eluting Coronary Stent System is the most studied reliable Biodegradable Polymer-DES, with over 50,000 patients worldwide.
Ultimaster™ Tansei™ Sirolimus Eluting Coronary Stent System is the most studied reliable Biodegradable Polymer-DES, with over 50,000 patients worldwide.